Many studies have aimed to measure CGRP concentrations in different extracellular compartments as a measure of activation of nociceptive trigeminal afferents in preclinical models of headache and orofacial pain [9–14] as well as in clinical studies [15–18]. This evidence concerns the gene CALCA and Headache.